![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 26, 19439-19442, June 30, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Amyloid Plaques of Alzheimer's Disease
Represent the Redox-silencing and Entombment of A
by Zinc*
§¶,
,
**,
,
,
,
,
,
, and

From the A
Laboratory for Oxidation Biology, Genetics
and Aging Unit, Massachusetts General Hospital, Charlestown,
Massachusetts 02129, the § Department of Psychiatry and
Behavioral Science, University of Auckland School of Medicine,
Auckland, New Zealand, the
Department of Pathology, Case Western
Reserve University, Cleveland, Ohio 44106, and the ** Department of
Psychiatry and Neurology, Asahikawa Medical College, Asahikawa
078-8510, Japan
binds Zn2+,
Cu2+, and Fe3+ in vitro, and these
metals are markedly elevated in the neocortex and especially enriched
in amyloid plaque deposits of individuals with Alzheimer's disease
(AD). Zn2+ precipitates A
in vitro, and
Cu2+ interaction with A
promotes its neurotoxicity,
correlating with metal reduction and the cell-free generation of
H2O2 (A
1-42 > A
1-40 > ratA
1-40). Because Zn2+ is redox-inert, we studied the
possibility that it may play an inhibitory role in
H2O2-mediated A
toxicity. In competition to the cytotoxic potentiation caused by coincubation with
Cu2+, Zn2+ rescued primary cortical and human
embryonic kidney 293 cells that were exposed to A
1-42, correlating
with the effect of Zn2+ in suppressing
Cu2+-dependent H2O2
formation from A
1-42. Since plaques contain exceptionally high
concentrations of Zn2+, we examined the relationship
between oxidation (8-OH guanosine) levels in AD-affected tissue and
histological amyloid burden and found a significant negative
correlation. These data suggest a protective role for Zn2+
in AD, where plaques form as the result of a more robust
Zn2+ antioxidant response to the underlying oxidative attack.

To whom correspondence should be addressed: Director,
Laboratory for Oxidation Biology, Massachusetts General Hospital, Bldg. 149, 13th St., Charlestown, MA 02129. Tel.: 617-726-8244; Fax: 617-724-9610; E-mail: bush@helix.mgh.harvard.edu.
This article has been cited by other articles:
![]() |
D. J. Tew, S. P. Bottomley, D. P. Smith, G. D. Ciccotosto, J. Babon, M. G. Hinds, C. L. Masters, R. Cappai, and K. J. Barnham Stabilization of Neurotoxic Soluble {beta}-Sheet-Rich Conformations of the Alzheimer's Disease Amyloid-{beta} Peptide Biophys. J., April 1, 2008; 94(7): 2752 - 2766. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-g. Lee, X. Zhu, R. J. Castellani, A. Nunomura, G. Perry, and M. A. Smith Amyloid-beta in Alzheimer Disease: The Null versus the Alternate Hypotheses J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 823 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Thomas and M. Fenech A review of genome mutation and Alzheimer's disease Mutagenesis, January 1, 2007; 22(1): 15 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nunomura, R. J. Castellani, H.-g. Lee, P. I. Moreira, X. Zhu, G. Perry, and M. A. Smith Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream. Sci. Aging Knowl. Environ., March 22, 2006; 2006(8): pe10 - pe10. [Abstract] [Full Text] |
||||
![]() |
R. J. Castellani, H.-g. Lee, G. Perry, and M. A. Smith Antioxidant protection and neurodegenerative disease: The role of amyloid-{beta} and tau American Journal of Alzheimer's Disease and Other Dementias, March 1, 2006; 21(2): 126 - 130. [Abstract] [PDF] |
||||
![]() |
A. K. Tickler, D. G. Smith, G. D. Ciccotosto, D. J. Tew, C. C. Curtain, D. Carrington, C. L. Masters, A. I. Bush, R. A. Cherny, R. Cappai, et al. Methylation of the Imidazole Side Chains of the Alzheimer Disease Amyloid-{beta} Peptide Results in Abolition of Superoxide Dismutase-like Structures and Inhibition of Neurotoxicity J. Biol. Chem., April 8, 2005; 280(14): 13355 - 13363. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Ciccotosto, D. Tew, C. C. Curtain, D. Smith, D. Carrington, C. L. Masters, A. I. Bush, R. A. Cherny, R. Cappai, and K. J. Barnham Enhanced Toxicity and Cellular Binding of a Modified Amyloid {beta} Peptide with a Methionine to Valine Substitution J. Biol. Chem., October 8, 2004; 279(41): 42528 - 42534. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-G. LEE, G. CASADESUS, X. ZHU, A. TAKEDA, G. PERRY, and M. A. SMITH Challenging the Amyloid Cascade Hypothesis: Senile Plaques and Amyloid-{beta} as Protective Adaptations to Alzheimer Disease Ann. N.Y. Acad. Sci., June 1, 2004; 1019(1): 1 - 4. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagano, X. Huang, R. D. Moir, S. M. Payton, R. E. Tanzi, and A. I. Bush Peroxidase Activity of Cyclooxygenase-2 (COX-2) Cross-links {beta}-Amyloid (A{beta}) and Generates A{beta}-COX-2 Hetero-oligomers That Are Increased in Alzheimer's Disease J. Biol. Chem., April 9, 2004; 279(15): 14673 - 14678. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. HUANG, R. D. MOIR, R. E. TANZI, A. I. BUSH, and J. T. ROGERS Redox-Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology Ann. N.Y. Acad. Sci., March 1, 2004; 1012(1): 153 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. HONDA, G. CASADESUS, R. B. PETERSEN, G. PERRY, and M. A. SMITH Oxidative Stress and Redox-Active Iron in Alzheimer's Disease Ann. N.Y. Acad. Sci., March 1, 2004; 1012(1): 179 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Barnham, G. D. Ciccotosto, A. K. Tickler, F. E. Ali, D. G. Smith, N. A. Williamson, Y.-H. Lam, D. Carrington, D. Tew, G. Kocak, et al. Neurotoxic, Redox-competent Alzheimer's {beta}-Amyloid Is Released from Lipid Membrane by Methionine Oxidation J. Biol. Chem., October 31, 2003; 278(44): 42959 - 42965. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Abramov, L. Canevari, and M. R. Duchen Changes in Intracellular Calcium and Glutathione in Astrocytes as the Primary Mechanism of Amyloid Neurotoxicity J. Neurosci., June 15, 2003; 23(12): 5088 - 5095. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Maynard, R. Cappai, I. Volitakis, R. A. Cherny, A. R. White, K. Beyreuther, C. L. Masters, A. I. Bush, and Q.-X. Li Overexpression of Alzheimer's Disease Amyloid-beta Opposes the Age-dependent Elevations of Brain Copper and Iron J. Biol. Chem., November 15, 2002; 277(47): 44670 - 44676. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Squitti, D. Lupoi, P. Pasqualetti, G. Dal Forno, F. Vernieri, P. Chiovenda, L. Rossi, M. Cortesi, E. Cassetta, and P. M. Rossini Elevation of serum copper levels in Alzheimer's disease Neurology, October 22, 2002; 59(8): 1153 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Opazo, X. Huang, R. A. Cherny, R. D. Moir, A. E. Roher, A. R. White, R. Cappai, C. L. Masters, R. E. Tanzi, N. C. Inestrosa, et al. Metalloenzyme-like Activity of Alzheimer's Disease beta -Amyloid. Cu-DEPENDENT CATALYTIC CONVERSION OF DOPAMINE, CHOLESTEROL, AND BIOLOGICAL REDUCING AGENTS TO NEUROTOXIC H2O2 J. Biol. Chem., October 18, 2002; 277(43): 40302 - 40308. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Mohajeri, K. Saini, J. G. Schultz, M. A. Wollmer, C. Hock, and R. M. Nitsch Passive Immunization against beta -Amyloid Peptide Protects Central Nervous System (CNS) Neurons from Increased Vulnerability Associated with an Alzheimer's Disease-causing Mutation J. Biol. Chem., August 30, 2002; 277(36): 33012 - 33017. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zou, J.-S. Gong, K. Yanagisawa, and M. Michikawa A Novel Function of Monomeric Amyloid beta -Protein Serving as an Antioxidant Molecule against Metal-Induced Oxidative Damage J. Neurosci., June 15, 2002; 22(12): 4833 - 4841. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Bush and R. E. Tanzi The galvanization of beta -amyloid in Alzheimer's disease PNAS, May 28, 2002; 99(11): 7317 - 7319. [Full Text] [PDF] |
||||
![]() |
S. Melov, S. R. Doctrow, J. A. Schneider, J. Haberson, M. Patel, P. E. Coskun, K. Huffman, D. C. Wallace, and B. Malfroy Lifespan Extension and Rescue of Spongiform Encephalopathy in Superoxide Dismutase 2 Nullizygous Mice Treated with Superoxide Dismutase-Catalase Mimetics J. Neurosci., November 1, 2001; 21(21): 8348 - 8353. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. Sunderman Jr. Nasal Toxicity, Carcinogenicity, and Olfactory Uptake of Metals Ann. Clin. Lab. Sci., January 1, 2001; 31(1): 3 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. SMITH, J. A. JOSEPH, and G. PERRY Arson: Tracking the Culprit in Alzheimer's Disease Ann. N.Y. Acad. Sci., December 1, 2000; 924(1): 35 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoshiike, K. Tanemura, O. Murayama, T. Akagi, M. Murayama, S. Sato, X. Sun, N. Tanaka, and A. Takashima New Insights on How Metals Disrupt Amyloid beta -Aggregation and Their Effects on Amyloid-beta Cytotoxicity J. Biol. Chem., August 17, 2001; 276(34): 32293 - 32299. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Curtain, F. Ali, I. Volitakis, R. A. Cherny, R. S. Norton, K. Beyreuther, C. J. Barrow, C. L. Masters, A. I. Bush, and K. J. Barnham Alzheimer's Disease Amyloid-beta Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits J. Biol. Chem., June 1, 2001; 276(23): 20466 - 20473. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |